General Information of Drug (ID: DM9HRZJ)

Drug Name
PMID26924192-Compound-106 Drug Info
Cross-matching ID
PubChem CID
86277842
TTD Drug ID
DM9HRZJ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
OTX-015 DMI8RG1 Acute myeloid leukaemia 2A60 Phase 1/2 [2]
ABBV-744 DMTEA9C Acute myeloid leukaemia 2A60 Phase 1 [3]
PMID26924192-Compound-104 DM346EU N. A. N. A. Patented [1]
PMID26924192-Compound-102 DMEJ107 N. A. N. A. Patented [1]
PMID26924192-Compound-103 DMWOCP7 N. A. N. A. Patented [1]
PMID26924192-Compound-105 DMAWLGI N. A. N. A. Patented [1]
Pyrrolo-pyrrolone derivative 1 DMN4SE5 N. A. N. A. Patented [1]
XD14 DMUMACD Discovery agent N.A. Investigative [4]
GW841819X DMRL9IN Discovery agent N.A. Investigative [5]
PMID24000170C36 DMHUWZS Discovery agent N.A. Investigative [6]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bromodomain-containing protein 2 (BRD2) TTDP48B BRD2_HUMAN Inhibitor [1]

References

1 BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22.
2 Targeting bromodomains: epigenetic readers of lysine acetylation.Nat Rev Drug Discov.2014 May;13(5):337-56.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 4-Acyl pyrroles: mimicking acetylated lysines in histone code reading. Angew Chem Int Ed Engl. 2013 Dec 23;52(52):14055-9.
5 Discovery and characterization of small molecule inhibitors of the BET family bromodomains. J Med Chem. 2011 Jun 9;54(11):3827-38.
6 Naphthyridines as novel BET family bromodomain inhibitors. ChemMedChem. 2014 Mar;9(3):580-9.